Zhejiang Orient Gene Biotech Co., Ltd

¥18.49As of Sun 8 Nov 2026, 12:00 UTC
SSE:688298Healthcare
Country China
PE (Fwd) •••
TSR 7Y CAGR (15.07%)
Div yield —
ROE (11.05%)
Medical Devices
Beta (5Y) 0.92
PE TTM —
TSR TTM (30.62%)
Mkt cap ¥3.539B
ROIC (10.42%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥23
22.58%
(77.37%)
Hold 1|10|3|11|11
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.22
0.23
0.25
0.27
24.17%
23.02%
31.35%
30.51%
Revenue¥M
196.4
200.1
195.8
191.9
(3.84%)
(0.65%)
(1.75%)
(4.97%)
Peers (US$530.5M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
2.006
0.320
0.215
EBIT/Intx
1.223
0.368
0.339
Own earn%
71.06
69.84
56.67
Sh yield%
43.77
6.19
5.31
Owners
Insiders/Inst%
3.62
45.76
Short interest%
5.21
SBC / revenue%
2.92
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
5–13
$1 testx
2.6
Incr. ROIC%
5